Normal and abnormal epithelial differentiation in the female reproductive tract

Differentiation

Volumn 82, Issue 3, 2011, Pages 117-126

  Kurita, Takeshi ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adenosis; Clear cell adenocarcinoma; Diethylstilbestrol (DES); P63; Squamous metaplasia; Wnt

Indexed keywords

BETA CATENIN; DIETHYLSTILBESTROL; ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR P63; UNCLASSIFIED DRUG; WNT4 PROTEIN; WNT7A PROTEIN;

ADENOCARCINOMA; CANCER RISK; CELL DIFFERENTIATION; CELL FATE; CERVICAL ADENOSIS; CLEAR CELL ADENOCARCINOMA; COLUMNAR EPITHELIUM; EMBRYONIC STRUCTURES; ENDOMETRIUM; EPITHELIAL DIFFERENTIATION; EPITHELIUM CELL; FEMALE GENITAL SYSTEM; HUMAN; MALIGNANT TRANSFORMATION; MESENCHYME; MUELLERIAN DUCT; MULLERIAN VAGINA; NONHUMAN; ORGANOGENESIS; PAPILLOMAVIRUS INFECTION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SQUAMOUS CELL METAPLASIA; SQUAMOUS EPITHELIUM; UTERINE CERVIX; UTERINE CERVIX CARCINOMA; UTERINE CERVIX EPITHELIUM; UTERINE CERVIX TUMOR; UTERINE SQUAMOUS METAPLASIA; UTERUS; VAGINA; VAGINA ADENOSIS; VAGINA EPITHELIUM;

ADENOCARCINOMA, CLEAR CELL; ANIMALS; CELL DIFFERENTIATION; CERVIX UTERI; DIETHYLSTILBESTROL; EPITHELIAL CELLS; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; MESODERM; METAPLASIA; MULLERIAN DUCTS; ORGANOGENESIS; UTERINE NEOPLASMS; UTERUS; VAGINA;

MAMMALIA;

EID: 80052368566     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2011.04.008     Document Type: Review

References (117)

1. Accetta S.G., Rivoire W.A., Monego H.I., Vettori D.V., De Oliveira Freitas D.M., Edelweiss M.I., Capp E. Vaginal adenosis in a non-diethylstilbestrol-exposed 6-year-old patient. Gynecologic and Obstetric Investigation 2001, 51:271-273.
2. Acién P. Embryological observations on the female genital tract. Human Reproduction (Oxford, England) 1992, 7:437-445.
3. Arey L.B. Developmental Anatomy: A Textbook and Laboratory Manual of Embryology 1954, W.B. Saunders, Philadelphia.
4. Bloomfield A., Frazer J.E. The development of the lower end of the vagina. Journal of Anatomy 1927, 62:9-32.
5. Boutin E.L., Battle E., Cunha G.R. The response of female urogenital tract epithelia to mesenchymal inductors is restricted by the germ layer origin of the epithelium: prostatic inductions. Differentiation; Research in Biological Diversity 1991, 48:99-105.
6. Boutin E.L., Battle E., Cunha G.R. The germ layer origin of mouse vaginal epithelium restricts its responsiveness to mesenchymal inductors: uterine induction. Differentiation; Research in Biological Diversity 1992, 49:101-107.
7. Boutin E.L., Sanderson R.D., Bernfield M., Cunha G.R. Epithelial-mesenchymal interactions in uterus and vagina alter the expression of the cell surface proteoglycan, syndecan. Developmental Biology 1991, 148:63-74.
8. Boyd J., Takahashi H., Waggoner S.E., Jones L.A., Hajek R.A., Wharton J.T., Liu F.S., Fujino T., Barrett J.C., McLachlan J.A. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero. Cancer 1996, 77:507-513.
9. Brody J.R., Cunha G.R. Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice: I. Normal development. The American Journal of Anatomy 1989, 186:1-20.
10. Bulmer D. The development of the human vagina. Journal of Anatomy 1957, 91:490-509.
11. Bulmer D. The epithelium of the urogenital sinus in female human foetuses. Journal of Anatomy 1959, 93:491-498.
12. Cadigan K.M., Peifer M. Wnt signaling from development to disease: insights from model systems. Cold Spring Harbor Perspectives in Biology 2009, 1:a002881.
13. Cai Y. Revisiting old vaginal topics: conversion of the Mullerian vagina and origin of the "sinus" vagina. The International Journal of Developmental Biology 2009, 53:925-934.
14. Carlson B.M. Human Embryology and Developmental Biology 1999, Mosby, St. Louis.
15. Carta L., Sassoon D. Wnt7a is a suppressor of cell death in the female reproductive tract and is required for postnatal and estrogen-mediated growth. Biology of Reproduction 2004, 71:444-454.
16. Castellsague X., Diaz M., de Sanjose S., Munoz N., Herrero R., Franceschi S., Peeling R.W., Ashley R., Smith J.S., Snijders P.J., Meijer C.J., Bosch F.X. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. Journal of the National Cancer Institute 2006, 98:303-315.
17. Chattopadhyay I., Cruickshan D.J., Packer M. Non diethylstilbesterol induced vaginal adenosis-a case series and review of literature. European Journal of Gynaecological Oncology 2001, 22:260-262.
18. Clifford G.M., Smith J.S., Plummer M., Munoz N., Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. British Journal of Cancer 2003, 88:63-73.
19. Colborn T. Pesticides--how research has succeeded and failed to translate science into policy: endocrinological effects on wildlife. Environmental Health Perspective 1995, 103(Suppl. 6):81-85.
20. Cunha G.R. The dual origin of vaginal epithelium. The American Journal of Anatomy 1975, 143:387-392.
21. Cunha G.R. Stromal induction and specification of morphogenesis and cytodifferentiation of the epithelia of the Müllerian ducts and urogenital sinus during development of the uterus and vagina in mice. The Journal of Experimental Zoology 1976, 196:361-370.
22. Daniely Y., Liao G., Dixon D., Linnoila R.I., Lori A., Randell S.H., Oren M., Jetten A.M. Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium. American Journal of Physiology and Cell Physiology 2004, 287:C171-181.
23. Darwiche N., Celli G., Sly L., Lancillotti F., De Luca L.M. Retinoid status controls the appearance of reserve cells and keratin expression in mouse cervical epithelium. Cancer Research 1993, 53:2287-2299.
24. DasGupta R., Fuchs E. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development (Cambridge, England) 1999, 126:4557-4568.
25. Del Vecchio F.R. Development of the caudal portions of the Mullerian ducts in the rat (Rattus norvegicus). Acta Anatomica (Basel) 1982, 113:235-245.
26. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., Zoeller R.T., Gore A.C. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocrine Reviews 2009, 30:293-342.
27. Drews U. Helper function of the Wolffian ducts and role of androgens in the development of the vagina. Sex Development 2007, 1:100-110.
28. Drews U., Sulak O., Schenck P.A. Androgens and the development of the vagina. Biology of Reproduction 2002, 67:1353-1359.
29. Ferris D.G. Anatomy and histology of normal female lower genital tract. Modern Colposcopy: Textbook and Atlas 2004, 13-40. Kendall Hunt, Dubuque. D.G. Ferris, J.T. Cox, D.M. O'Connor, V.C. Wright, J. Foerster (Eds.).
30. Fliegner J.R.H. Vaginal agenesis and the embryology of vaginal epithelium. The Australian & New Zealand Journal of Obstetrics & Gynaecology 1994, 34:562-566.
31. Forsberg J.G. Derivation and differentiation of the vaginal epithelium 1963, The Institute of Anatomy, LUND, p. 197.
32. Forsberg J.G. An experimental approach to the problem of the derivation of the vaginal epithelium. Journal of Embryology and Experimental Morphology 1965, 14:213-222.
33. Forsberg J.G. Cervicovaginal epithelium: its origin and development. American Journal of Obstetrics and Gynecology 1973, 115:1025-1043.
34. Forsberg J.G. Animal model of human disease: adenosis and clear-cell carcinomas of vagina and cervix. The American Journal of Pathology 1976, 84:669-672.
35. Forsberg J.G. Development of the human vaginal epithelium. The Human Vagina 1978, 3-19. North-Holland, New York. E.S.E. Hafez, T.N. Evans (Eds.).
36. Franco H.L., Dai D., Lee K.Y., Rubel C.A., Roop D., Boerboom D., Jeong J.W., Lydon J.P., Bagchi I.C., Bagchi M.K., Demayo F.J. WNT4 is a key regulator of normal postnatal uterine development and progesterone signaling during embryo implantation and decidualization in the mouse. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2010.
37. Frutiger P. On the early development of the ductus paramesonephricus and the Mullerian capsule in man. Acta Anatomica 1969, 72:233-245.
38. Gilbert S.F. Developmental Biology 2003, Sinauer Associates, Sunderland.
39. Gitlin G. On the mode of development of stratified squamous epithelium in the rat's uterus following prolonged estrogen administration. The Anatomical Record 1954, 120:637-661.
40. Giusti R.M., Iwamoto K., Hatch E.E. Diethylstilbestrol revisited: a review of the long-term health effects. Annals of Internal Medicine 1995, 122:778-788.
41. Goto K., Takeuchi Y., Yakihara A., Kotsuji F. Synchronous invasive squamous cell carcinoma and clear cell adenocarcinoma of the uterine cervix: a different human papillomavirus status. Gynecologic Oncology 2005, 97:976-979.
42. Grigoryan T., Wend P., Klaus A., Birchmeier W. Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes & Development 2008, 22:2308-2341.
43. Grünwald P. The relation of the growing tip of the Müllerian duct to the Wolffian duct and its importance for the genesis of malformations. The Anatomical Record 1941, 81:1-19.
44. Guioli S., Sekido R., Lovell-Badge R. The origin of the Müllerian duct in chick and mouse. Developmental Biology 2007, 302:389-398.
45. Hart D.B. Preliminary Note on the development of the clitoris, vagina, and hymen. Journal of Anatomy and Physiology 1896, 31(18-28):11.
46. Hart D.B. Morphology of the Human Urinogenital Tract. Journal of Anatomy and Physiology 1901, 35:330-375.
47. Hashimoto R. Development of the human Müllerian duct in the sexually undifferentiated stage. Anatomical Record. A Discovery of Molecular and Cell Evolution Biology 2003, 272:514-519.
48. Hatch E.E., Palmer J.R., Titus-Ernstoff L., Noller K.L., Kaufman R.H., Mittendorf R., Robboy S.J., Hyer M., Cowan C.M., Adam E., Colton T., Hartge P., Hoover R.N. Cancer risk in women exposed to diethylstilbestrol in utero. JAMA: The Journal of the American Medical Association 1998, 280:630-634.
49. Hayashi K., Erikson D.W., Tilford S.A., Bany B.M., Maclean J.A., Rucker E.B., Johnson G.A., Spencer T.E. Wnt genes in the mouse uterus: potential regulation of implantation. Biology of Reproduction 2009, 80:989-1000.
50. Herbst A.L. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES). Gynecologic Oncology 2000, 76:147-156.
51. Herbst A.L., Poskanzer D.C., Robboy S.J., Friedlander L., Scully R.E. Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls. The New England Journal of Medicine 1975, 292:334-339.
52. Herbst A.L., Scully R.E. Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer 1970, 25:745-757.
53. Herbst A.L., Ulfelder H., Poskanzer D.C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. The New England Journal of Medicine 1971, 284:878-881.
54. Huelsken J., Vogel R., Erdmann B., Cotsarelis G., Birchmeier W. Beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 2001, 105:533-545.
55. Jeong J.W., Lee H.S., Franco H.L., Broaddus R.R., Taketo M.M., Tsai S.Y., Lydon J.P., DeMayo F.J. Beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus. Oncogene 2009, 28:31-40.
56. Johnson L.D., Driscoll S.G., Hertig A.T., Cole P.T., Nickerson R.J. Vaginal adenosis in stillborns and neonates exposed to diethylstilbestrol and steroidal estrogens and progestins. Obstetrics and Gynecology 1979, 53:671-679.
57. Josso N., di Clemente N., Gouedard L. Anti-mullerian hormone and its receptors. Molecular and Cellular Endocrinology 2001, 179:25-32.
58. Kobayashi A., Behringer R.R. Developmental genetics of the female reproductive tract in mammals. Nature Reviews Genetics 2003, 4:969-980.
59. Koff A.K. Development of the vagina in the human fetus. Contributions to Embryology 1933, 24:59-91.
60. Komatsu M., Fujita H. Electron-microscopic studies on the development and aging of the epithelium of mice. Anatomy and Embryology (Berlin) 1978, 152:243-259.
61. Korinek V., Barker N., Moerer P., van Donselaar E., Huls G., Peters P.J., Clevers H. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genetics 1998, 19:379-383.
62. Kurita T. Developmental origin of vaginal epithelium. Differentiation; Research in Biological Diversity 2010, 80:99-105.
63. Kurita T., Cooke P.S., Cunha G.R. Epithelial-stromal tissue interaction in paramesonephric (Müllerian) epithelial differentiation. Developmental Biology 2001, 240:194-211.
64. Kurita T., Cunha G.R. Roles of p63 in differentiation of Müllerian duct epithelial cells. Annals of the New York Academy of Sciences 2001, 948:9-12.
65. Kurita T., Cunha G.R., Robboy S.J., Mills A.A., Medina R.T. Differential expression of p63 isoforms in female reproductive organs. Mechanisms of Development 2005, 122:1043-1055.
66. Kurita T., Lee K., Cooke P.S., Taylor J.A., Lubahn D.B., Cunha G.R. Paracrine regulation of epithelial progesterone receptor by estradiol in the mouse female reproductive tract. Biology of Reproduction 2000, 62:821-830.
67. Kurita T., Mills A.A., Cunha G.R. Roles of p63 in the diethylstilbestrol-induced cervicovaginal adenosis. Development (Cambridge, England) 2004, 131:1639-1649.
68. Kurita T., Nakamura H. Embryology of the uterus. Endometrium 2008, 1-18. Informa UK Ltd, London, UK. J.D. Aplin, A.T. Fazleabas, S.R. Glasser, L.C. Giudice (Eds.).
69. Kurman R.J., Scully R.E. The incidence and histogenesis of vaginal adenosis. An autopsy study. Human Pathology 1974, 5:265-276.
70. Liebrich C., Brummer O., Von Wasielewski R., Wegener G., Meijer C., Iftner T., Petry K.U. Primary cervical cancer truly negative for high-risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents. European Journal of Gynaecological Oncology 2009, 30:45-48.
71. Mauch R.B., Thiedemann K.U., Drews U. The vagina is formed by downgrowth of Wolffian and Müllerian ducts. Graphical reconstructions from normal and Tfm mouse embryos. Anatomy and Embryology (Berlin) 1985, 172:75-87.
72. McEuen C.S. Metaplasia of uterine epithelium produced in rats by prolonged administration of oestrin. American Journal of Cancer 1936, 27:91-94.
73. McLachlan J.A., Newbold R.R., Bullock B.C. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Research 1980, 40:3988-3999.
74. Melnick S., Cole P., Anderson D., Herbst A. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. The New England Journal of Medicine 1987, 316:514-516.
75. Miller C., Pavlova A., Sassoon D.A. Differential expression patterns of Wnt genes in the murine female reproductive tract during development and the estrous cycle. Mechanisms of Development 1998, 76:91-99.
76. Miller C., Sassoon D.A. Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development (Cambridge, England) 1998, 125:3201-3211.
77. Mills A.A., Zheng B., Wang X.J., Vogel H., Roop D.R., Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999, 398:708-713.
78. Minaguchi T., Yoshikawa H., Nakagawa S., Yasugi T., Yano T., Iwase H., Mizutani K., Shiromizu K., Ohmi K., Watanabe Y., Noda K., Nishiu M., Nakamura Y., Taketani Y. Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix. Cancer Letters 2004, 210:57-62.
79. Moll R., Levy R., Czernobilsky B., Hohlweg-Majert P., Dallenbach-Hellweg G., Franke W.W. Cytokeratins of normal epithelia and some neoplasms of the female genital tract. Laboratory Investigation; A Journal of Technical Methods and Pathology 1983, 49:599-610.
80. Moore K.L., Persaud T.V.N. The urogenital system. The Developing Human: Clinically Oriented Embryology 2002, 287-328. W B Saunders Co, Philadelphia. K.L. Moore, T.V.N. Persaud (Eds.).
81. Morris J.M. The syndrome of testicular feminization in male pseudohermaphrodites. American Journal of Obstetrics and Gynecology 1953, 65:1192-1211.
82. Nakamuta N., Kobayashi S. Developmental expression of p63 in the mouse testis. Journal of Veterinary Medical Science 2004, 66:681-687.
83. Nakamuta N., Kobayashi S. Expression of p63 in the mouse primordial germ cells. Journal of Veterinary Medical Science 2004, 66:1365-1370.
84. Newbold R.R., Jefferson W.N., Padilla-Banks E. Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environmental Health Perspective 2009, 117:879-885.
85. Newbold R.R., McLachlan J.A. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol. Cancer Research 1982, 42:2003-2011.
86. O'Rahilly R. The embryology and anatomy of the uterus. The Uterus 1973, 17-39. The Williams & Wilkins Co., Baltimore. R.M. Wynn (Ed.).
87. Orvis G.D., Behringer R.R. Cellular mechanisms of Müllerian duct formation in the mouse. Developmental Biology 2007, 306:493-504.
88. Parr B.A., Avery E.J., Cygan J.A., McMahon A.P. The classical mouse mutant postaxial hemimelia results from a mutation in the Wnt 7a gene. Developmental Biology 1998, 202:228-234.
89. Parr B.A., McMahon A.P. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 1998, 395:707-710.
90. Petre-Lazar B., Livera G., Moreno S.G., Trautmann E., Duquenne C., Hanoux V., Habert R., Coffigny H. The role of p63 in germ cell apoptosis in the developing testis. Journal of Cellular Physiology 2007, 210:87-98.
91. Petre-Lazar B., Moreno S.G., Livera G., Duquenne C., Habert R., Coffigny H. p63 expression pattern in foetal and neonatal gonocytes after irradiation and role in the resulting apoptosis by using p63 knockout mice. International Journal of Radiation Biology 2006, 82:771-780.
92. Pirog E.C., Kleter B., Olgac S., Bobkiewicz P., Lindeman J., Quint W.G., Richart R.M., Isacson C. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. The American Journal of Pathology 2000, 157:1055-1062.
93. Plapinger L., Bern H.A. Adenosis-like lesions and other cervicovaginal abnormalities in mice treated perinatally with estrogen. Journal of the National Cancer Institute 1979, 63:507-518.
94. Quigley C.A., De Bellis A., Marschke K.B., el-Awady M.K., Wilson E.M., French F.S. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocrine Reviews 1995, 16:271-321.
95. Robboy S.J., Hill E.C., Sandberg E.C., Czernobilsky B. Vaginal adenosis in women born prior to the diethylstilbestrol era. Human Pathology 1986, 17:488-492.
96. Robboy S.J., Young R.H., Welch W.R., Truslow G.Y., Prat J., Herbst A.L., Scully R.E. Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. Cancer 1984, 54:869-875.
97. Russell D.L. Embryology. Benign Diseases of the Vulva and Vagina 1989, 16-25. Year Book Medical Publishers, Chicago. R.H. Kaufman, E.G.J. Friedrich, H.L. Gardner (Eds.).
98. Sadler T.W. Urogenital system. Langman's Medical Embryology 2004, 321-362.
99. Saito K., Kawakami S., Okada Y., Takazawa R., Koga F., Kageyama Y., Kihara K. Spatial and isoform specific p63 expression in the male human urogenital tract. The Journal of Urology 2006, 176:2268-2273.
100. Sajjad Y. Development of the genital ducts and external genitalia in the early human embryo. Journal of Obstetrics and Gynaecology Research 2010, 36:929-937.
101. Sánchez-Ferrer M.L., Acien M.I., Sanchez del Campo F., Mayol-Belda M.J., Acien P. Experimental contributions to the study of the embryology of the vagina. Human Reproduction (Oxford, England) 2006, 21:1623-1628.
102. Selye H., Thomson D.L., Collip J.B. Metaplasia of uterine epithelium produced by chronic œstrin administration. Nature 1935, 135:65-66.
103. Shapiro E., Huang H.Y., Wu X.R. Uroplakin and androgen receptor expression in the human fetal genital tract: insights into the development of the vagina. The Journal of Urology 2000, 164:1048-1051.
104. Sherman A.I., Goldrath M., Berlin A., Vakhariya V., Banooni F., Michaels W., Goodman P., Brown S. Cervical-vaginal adenosis after in utero exposure to synthetic estrogens. Obstetrics and Gynecology 1974, 44:531-545.
105. Signoretti S., Waltregny D., Dilks J., Isaac B., Lin D., Garraway L., Yang A., Montironi R., McKeon F., Loda M. p63 is a prostate basal cell marker and is required for prostate development. The American Journal of Pathology 2000, 157:1769-1775.
106. Stewart J., Bevans-Wilkins K., Ye C., Kurtycz D.F. Clear-cell endocervical adenocarcinoma in a 19-year-old woman. Diagnostic Cytopathology 2006, 34:839-842.
107. Teixeira J., Maheswaran S., Donahoe P.K. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocrine Reviews 2001, 22:657-674.
108. Torres M., Gomez-Pardo E., Dressler G.R., Gruss P. Pax-2 controls multiple steps of urogenital development. Development (Cambridge, England) 1995, 121:4057-4065.
109. Ulfelder H., Robboy S.J. The embryologic development of the human vagina. American Journal of Obstetrics and Gynecology 1976, 126:769-776.
110. Verloop J., van Leeuwen F.E., Helmerhorst T.J., van Boven H.H., Rookus M.A. Cancer risk in DES daughters. Cancer Causes & Control: CCC 2010, 21:999-1007.
111. Wang J., Shackleford G.M. Murine Wnt10a and Wnt10b: cloning and expression in developing limbs, face and skin of embryos and in adults. Oncogene 1996, 13:1537-1544.
112. Witschi E. Development and differentiation of the uterus. Prenatal Life 1970, 11-34. Wayne State University Press, Detroit. H.C. Mack (Ed.).
113. Wolbach S.B., Howe P.R. Tissue changes following deprivation of fat-soluble a vitamin. Journal of Experimental Medicine 1925, 42:753-777.
114. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M.D., Dotsch V., Andrews N.C., Caput D., McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Molecular Cell 1998, 2:305-316.
115. Yang A., Schweitzer R., Sun D., Kaghad M., Walker N., Bronson R.T., Tabin C., Sharpe A., Caput D., Crum C., McKeon F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999, 398:714-718.
116. Yin Y., Ma L. Development of the mammalian female reproductive tract. Journal of Biochemistry (Tokyo) 2005, 137:677-683.
117. Zhan Y., Fujino A., MacLaughlin D.T., Manganaro T.F., Szotek P.P., Arango N.A., Teixeira J., Donahoe P.K. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression. Development (Cambridge, England) 2006, 133:2359-2369.